Skip to content

Trial Comparing Laparoscopic Vs Robotic-assisted Colposacropexy for Pelvic Organ Prolapse Repair

Perspective Randomized Trial Comparing Laparoscopic Vs Robotic-assisted Colposacropexy for Pelvic Organ Prolapse Repair

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02852512
Enrollment
62
Registered
2016-08-02
Start date
2016-03-31
Completion date
2018-03-31
Last updated
2016-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

Laparoscopic Sacrocolpopexy, Robotic Assisted Sacrocolpopexy, Pelvic Organ Prolapse

Brief summary

The aim of the study is to perspectively compare the anatomical and functional outcomes of Pelvic Organ Prolapse (POP) repair after Laparoscopic or Robotic-assisted Colposacropexy.

Detailed description

Female pelvic floor disorders rank amongst the most common disorders affecting women and include conditions such as urinary incontinence and pelvic organ prolapse (POP). POP is estimated to affect 30% of women aged 50- 89 years, and the lifetime risk of requiring surgery is 11%. Open abdominal sacrocolpopexy is the established gold standard procedure and is indicated when there is prolapse of the anterior and/or apical vaginal wall compartments. Laparoscopic sacrocolpopexy (LSCP) has not been widely adopted as it demands skill and motivation and it is associated with a long learning curve. So the hypothesis is that robot-assisted laparoscopic approach for sacrocolpopexy (RALSCP) could be an alternative to a pure laparoscopic technique. In the study design 62 patients will be randomly enrolled (31 in the laparoscopic arm and 31 in the robotic assisted one). The primary outcome will be the anatomic one, secondary outcomes will be functional in terms of storage or voiding dysfunctions, sexual dysfunctions, bowel dysfunctions, QoL, post operative complications. For continuous variables will be used the Mann-Withney test, for categorical data will be used McNemar test and X2 test.

Interventions

Peritoneal incision from the sacral promontory to the Pouch of Douglas. After careful dissection of the inter-rectovaginal space, a two-piece Y-shaped polypropylene mesh was fixed posteriorly to the levator ani muscles using a absorbable suture. The midpoint of the mesh is anchored to the posterior wall of the vagina. The anterior portion of mesh was then introduced and fixed within the intervesico- vaginal space to the anterior/apical vaginal wall with a running suture. The tails of both meshes were fixed to the sacral promontory with a strong non-absorbable polypropylene suture. The peritoneal incision was re- approximated with a running absorbable suture

Sponsors

University Of Perugia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic POP \>2 stage according to POP Q system

Exclusion criteria

* Obesity * Heart failure (NYHA III-IV) * High stage COPD (Chronic Obstructive Pulmonary Disease) * Patients who underwent more than 2 previous abdominal surgical procedures

Design outcomes

Primary

MeasureTime frameDescription
Anatomical outcome12 monthsPOP \<2 according to POP-Q system

Secondary

MeasureTime frameDescription
post operative painwithin 7 days after surgeryVAS score (Visual Analog Pain Scale)
voiding and storage symptoms2, 6, 12 months after surgeryfill in Urinary Distress Inventory short form (UDI-6) to assess urinary symptoms
Intraoperative ando post operative complicationsduring surgery and within 90 days after surgeryClavien-Dindo classification of surgery complications
patient satisfaction12 months after surgeryfill in Patient Global Impression of Improvement (PGI-I)
Quality of life2, 6, 12 monthsfill in Incontinence Impact Questionnaire-Short form (IIQ-7)
sexual dysfunctions2, 6, 12 months after surgeryfill in Female Sexual Function Index questionnaire (FSFI)

Countries

Italy

Contacts

Primary ContactElisabetta Costantini, MD
elisabetta.costantini@unipg.it+393393384370
Backup ContactEster Illiano, MD
ester.illiano@inwind.it+393283620614

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026